Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Selagine, Grifols agree to develop, commercialise immunoglobulin eye drops
Selagine has signed a research, development and sublicense agreement with Grifols for the development and commercialisation of immunoglobulin eye drops for dry eye disease.
Ophthalmology
-
07 Mar 2023
-
19 Jan 2023
Exegenesis Bio receives US FDA clearance for EXG102-031 IND application
Exegenesis Bio has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug (IND) application for gene therapy EXG102-031.
-
20 Jul 2022
Avista Therapeutics, Roche partner to develop AAV gene therapy vectors for eyes
Avista Therapeutics has announced partnership with Roche to develop new AAV gene therapy vectors for the eyes.
-
13 Apr 2022
Aurion Biotech raises $120m to advance cell therapy programme
Aurion Biotech has raised $120m from biotech and ophthalmology investors to progress its cell therapy programme for corneal edema secondary to endothelial dysfunction.